| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 994 |
| 1 | 0XYGEN | 540 |
| 2 | OXYGEN | 540 |
| 3 | AMBRISENTAN | 480 |
| 4 | MACITENTAN | 476 |
| 5 | SILDENAFIL CITRATE | 432 |
| 6 | TADALAFIL | 362 |
| 7 | SILDENAFIL | 315 |
| 8 | FUROSEMIDE | 287 |
| 9 | SELEXIPAG | 231 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | 0XYGEN | 540 | 0.0106 |
| 1 | OXYGEN | 540 | 0.0106 |
| 2 | SELEXIPAG | 231 | 0.0089 |
| 3 | EPOPROSTENOL | 108 | 0.0082 |
| 4 | TREPROSTINIL | 994 | 0.0078 |
| 5 | SOTATERCEPT-CSRK | 48 | 0.0078 |
| 6 | MACITENTAN | 476 | 0.0068 |
| 7 | RIOCIGUAT | 180 | 0.0055 |
| 8 | NINTEDANIB | 175 | 0.0054 |
| 9 | ERGOCALCIFEROL | 149 | 0.0050 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 1034 |
| 1 | Endothelin Receptor Antagonist [EPC] | 944 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 530 |
| 3 | Loop Diuretic [EPC] | 380 |
| 4 | Corticosteroid [EPC] | 252 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 248 |
| 6 | Prostacyclin Receptor Agonist [EPC] | 231 |
| 7 | Factor Xa Inhibitor [EPC] | 190 |
| 8 | Soluble Guanylate Cyclase Stimulator [EPC] | 180 |
| 9 | Osmotic Laxative [EPC] | 177 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD25-directed Cytotoxin [EPC] | 1 | 0.1000 |
| 1 | Prostacyclin Receptor Agonist [EPC] | 231 | 0.0089 |
| 2 | Interleukin-5 Antagonist [EPC] | 6 | 0.0087 |
| 3 | Prostacycline Vasodilator [EPC] | 1034 | 0.0075 |
| 4 | Soluble Guanylate Cyclase Stimulator [EPC] | 180 | 0.0053 |
| 5 | Provitamin D2 Compound [EPC] | 149 | 0.0050 |
| 6 | Endothelin Receptor Antagonist [EPC] | 944 | 0.0047 |
| 7 | Surfactant [EPC] | 5 | 0.0043 |
| 8 | Non-Standardized House Dust Allergenic Extract [EPC] | 3 | 0.0040 |
| 9 | Phosphodiesterase 5 Inhibitor [EPC] | 530 | 0.0039 |